Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity (2017)
- Authors:
- Autor USP: SHINJO, SUELI MIEKO OBA - FM
- Unidade: FM
- Subjects: MIOSITE; FÁRMACOS IMUNOSSUPRESSORES; EVENTO ADVERSO A MEDICAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical and experimental rheumatology
- ISSN: 0392-856X
- Volume/Número/Paginação/Ano: v. 35, n. 6, p. 1011-1013, 2017
-
ABNT
SOUZA, R. C. de et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, v. 35, n. 6, p. 1011-1013, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25488. Acesso em: 25 fev. 2026. -
APA
Souza, R. C. de, Souza, F. H. C. de, Miossi, R., & Shinjo, S. M. O. (2017). Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, 35( 6), 1011-1013. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25488 -
NLM
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2026 fev. 25 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488 -
Vancouver
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2026 fev. 25 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488 - Alta prevalência de tabagismo em pacientes com artrite reumatóide de início precoce
- Lysyloxidase related genes identification by siRNA knockdown
- Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review
- Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies
- Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies: a longitudinal study
- Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
- Endothelial function features and properties of large vessel behavior in systemic autoimmune diseases: a cross-talk among cardiovascular disease risk factors
- Effect of atorvastatin on muscle tissues of dermatomyositis and antisynthetase syndrome patients with dyslipidemia
- Allotopic and orthotopic xenograft model for human glioma
- Distribuição do Tipo de Fibras Musculares e sua Correlação Genotípica na Doença de Pompe
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
